When was SCHOTT Pharma founded?

SCHOTT Pharma was founded in 1884 and raised its 1st funding round 142 years after it was founded.

Where is SCHOTT Pharma located?

SCHOTT Pharma is headquartered in Mainz, Germany.

How many employees does SCHOTT Pharma have?

As of Jul 31, 2026, the latest employee count at SCHOTT Pharma is 1281.

Is SCHOTT Pharma a funded company?

SCHOTT Pharma is a funded company, having raised a total of $***** in its 1st and only funding round, a Post IPO round on May 2026.

When was the latest funding round of SCHOTT Pharma?

SCHOTT Pharma's latest funding was a $***** Post IPO round on May 2026, with participation from 1 investor.

Where does SCHOTT Pharma rank among its competitors?

SCHOTT Pharma ranks 38th amongst 1076 active competitors, of which 71 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Ipsen, which secured $618K in Dec, 2023.

Who are the top competitors of SCHOTT Pharma?

SCHOTT Pharma's top competitors include WuXi AppTec, ANI Pharmaceuticals and EVERSANA. Among them, SCHOTT Pharma secured the most recent funding round in May, 2026.

SCHOTT Pharma - 2026 Company Profile, Funding & Competitors

SCHOTT Pharma is a public company based in Mainz (Germany), founded in 1884. It operates as a Provider of drug research & development, fill & finish, and regulatory affair services. SCHOTT Pharma has raised an undisclosed amount in funding. The company has 1076 active competitors, including 71 funded and 127 that have exited. Its top competitors include companies like WuXi AppTec, ANI Pharmaceuticals and EVERSANA.

Key Metrics

Founded Year

1884

Location

Mainz, Germany

Stage

Public

Latest Funding Round

Post IPO, May 2026, $*****

Ranked

38^th among 1076 active competitors

Employee Count

1,281 as on Jul 31, 2026

Similar Companies

WuXi AppTec & 1120 more

Exit Details

Public

View SCHOTT Pharma's full profile

SCHOTT Pharma is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Schott Ag CIN: HRB8555 , Germany, Active	Apr 04, 2004	-	2493 (As on Dec 31, 2021)
Schott Pharma Schweiz Ag CIN: 61521 , Switzerland, Active	Apr 17, 2024	-	-	-

SCHOTT Pharma got listed on Sep 28, 2023.

Click here to take a look at SCHOTT Pharma's IPO in detail

SCHOTT Pharma has raised funding over 1 round. Its latest funding round was a Post IPO round on May 2026 for $*****. 1 investor participated in its latest round.

Here is the list of recent funding rounds of SCHOTT Pharma:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 2026	8775291	Post IPO	1024145	3537645	7015950	1411859

Access funding benchmarks and valuations. Sign up today!

View details of SCHOTT Pharma's funding rounds and investors

SCHOTT Pharma's employee count trend

SCHOTT Pharma has 1,281 employees as of Jul 26. Here is SCHOTT Pharma's employee count trend over the years:

Uncover SCHOTT Pharma's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of SCHOTT Pharma include WuXi AppTec, ANI Pharmaceuticals and EVERSANA. Here is the list of Top 10 competitors of SCHOTT Pharma, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	WuXi AppTec 2000, Shanghai (China), Public	Provider of CRO and CDMO services	$40M	Synergis Capital, HongShan & 27 others	79/100
2nd	ANI Pharmaceuticals 1996, Baudette (United States), Public	Manufacturer of pharmaceutical products, including extended-release capsules and immediate-release tablets	-	Ampersand Capital, US Bank & 4 others	64/100
3rd	EVERSANA 2014, Milwaukee (United States), Funding Raised	Provider of consulting services for drug pricing access, reimbursement, and regulatory support	-	North Sky Capital, ACE & Company & 2 others	63/100
4th	Ipsen 1929, Paris (France), Public	Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes	-	Digital Pharma Lab, Qualium Investissement ... & 2 others	63/100
5th	Zuellig Pharma 1992, Singapore (Singapore), Funding Raised	Provider of clinical research, quality management, logistics, and clinical trial supply services	-	Temasek	61/100
6th	Eurofins Scientific 1987, Luxembourg (Luxembourg), Public	Provider of laboratory testing services and CRO contract research services	-	CDPQ, Holland Capital & 1 others	61/100
7th	Precision Medicine Group 2012, Bethesda (United States), Late Stage	Provider of clinical research, development, and commercialization services for life sciences	$532M	TPG, Blackstone & 7 others	60/100
8th	Curatio healthcare 2005, Chennai (India), Acquired	Provider of market research services for biopharma sector, and dermatology products for cosmetologists	$44.8M	Camel Investment Limited, ChrysCapital & 13 others	59/100
9th	China Medical System 1992, Shenzhen (China), Public	Manufacturer of generic formulations	-	CMS Ventures	55/100
10th	Avania 1988, Brunswick (Australia), Acquired	Provider of regulatory, clinical trials and analytic services	-	Kester Capital, Crescent Capital Group & 1 others	48/100
38th	SCHOTT Pharma 1884, Mainz (Germany), Public	Provider of drug research & development, fill & finish, and regulatory affair services	-	-	40/100